Results 51 to 60 of about 15,755,820 (216)

Management patterns of non-ST segment elevation acute coronary syndromes in relation to prior coronary revascularization [PDF]

, 2010
Contemporary guidelines support an early invasive strategy for non-ST elevation acute coronary syndrome (NSTE-ACS) patients who had prior coronary revascularization. However, little is known about the management pattern of these patients in "real world.
?, ?, Elbarasi, Esam, Kornder, Jan, Welsh, Robert C, Déry, Jean-Pierre, Goodman, Shaun G, Fox, Keith A A, Gore, Joel M, Yan, Andrew T, Wong, Graham C, Anderson, Fred, Yan, Raymond T, Esam Elbarasi, Robert C. Welsh, Jean-Pierre Déry, Joel M. Gore, Fred Anderson, Gore, Joel M., Raymond T. Yan, Goodman, Shaun G., Fox, Keith A. A., Canadian Acute Coronary Syndrome Registries I and II (ACS I and ACS II) Investigators, Welsh, Robert C., Keith A.A. Fox, Yan, Raymond T., Canadian Global Registry of Acute Coronary Events (GRACE/expanded-GRACE) Investigators, Yan, Andrew T., Wong, Graham C., Andrew T. Yan, Graham C. Wong, Shaun G. Goodman, Jan Kornder, Anderson, Frederick A. Jr.   +32 more
core   +1 more source

Management of the acute coronary syndromes

South African Family Practice, 2004
The clinical presentation with an acute coronary syndrome (ACS), is an indication of a serious event (atherosclerotic plaque rupture) occurring in the patient’s coronary artery.
J.M. Bennett
doaj   +1 more source

Coronary CT Angiography in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome

Journal of the American College of Cardiology, 2020
In patients with non-ST-segment elevation acute coronary syndrome (NSTEACS), coronary pathology may range from structurally normal vessels to severe coronary artery disease.The purpose of this study was to test if coronary computed tomography angiography (CTA) may be used to exclude coronary artery stenosis ≥50% in patients with NSTEACS.The VERDICT ...
Linde, Jesper J, Kelbæk, Henning, Hansen, Thomas Fritz, Sigvardsen, Per E, Torp-Pedersen, Christian Tobias, Bech, Jan, Heitmann, Merete, Nielsen, Olav W, Høfsten, Dan, Kühl, Jørgen T, Raymond, Ilan E, Kristiansen, Ole P, Svendsen, Ida H, Vall-Lamora, Maria H D, Kragelund, Charlotte, de Knegt, Martina, Hove, Jens D, Jørgensen, Tem, Fornitz, Gitte G, Steffensen, Rolf, Jurlander, Birgit, Abdulla, Jawdat, Lyngbæk, Stig, Elming, Hanne, Therkelsen, Susette K, Jørgensen, Erik, Kløvgaard, Lene, Bang, Lia Evi, Hansen, Peter Riis, Helqvist, Steffen, Galatius, Søren, Pedersen, Frants, Abildgaard, Ulrik, Clemmensen, Peter, Saunamäki, Kari, Holmvang, Lene, Engstrøm, Thomas, Gislason, Gunnar, Køber, Lars V, Kofoed, Klaus F   +39 more
openaire   +3 more sources

Clinical and prognostic comparison between left ventricular transient dyskinesia and a first non-ST-segment elevation acute coronary syndrome

, 2008
Objectives: Apical ballooning shares features with acute coronary syndromes. Recently, atypical forms have been reported without apical involvement. Usually, the prognostic reports have compared them with ST-segment elevation infarction. Left ventricular
Núñez Gil, Iván Javier, Zamorano Gómez, José Luis, Macaya Miguel, Carlos, Vivas Balcones, Luis David, González Armengol, Juan Jorge, Alonso, Joaquín, Luaces Méndez, María, García Rubira, Juan Carlos, Fernández Ortiz, Antonio Ignacio, Pérez De Isla, Leopoldo   +9 more
core   +1 more source

Less Bleeding by Omitting Aspirin in Non-ST-segment Elevation Acute Coronary Syndrome Patients (LEGACY)

, 2021
Rationale: Dual antiplatelet therapy, consisting of aspirin and a P2Y12-inhibitor, reduces the risk of stent thrombosis, myocardial infarction and stroke after coronary stent implantation.
N.M.R. van der Sangen (11844380)
core   +1 more source

Impact of Society Guidelines on Trends in Use of Newer P2Y12 Inhibitors for Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background Over the past decade, major society guidelines have recommended the use of newer P2Y12 inhibitors over clopidogrel for those undergoing percutaneous coronary intervention for acute coronary syndrome.
Mohamed O. Mohamed, Evangelos Kontopantelis, Mirvat Alasnag, Leila Abid, Amitava Banerjee, Andrew S. P. Sharp, Christos Bourantas, Alex Sirker, Nick Curzen, Mamas A. Mamas   +9 more
doaj   +1 more source

Place of Prasugrel, P2Y12 receptor antagonist, in an early invasive treatment of patients with acute coronary syndrome (according to the results of multicenter randomized controlled trial ISAR-REACT 5)

Российский кардиологический журнал, 2019
The conclusion of the Expert Council reports an agreement on the place of the P2Y12 receptor blocker prasugrel in the early invasive treatment of patients with acute coronary syndrome ACS, according to the results of the multicenter randomized controlled
S. N. Tereshchenko, M. G. Glezer, S. A. Abugov, O. V. Averkov, S. I. Antipov, A. S. Galyavich, M. Yu. Gilyarov, D. V. Duplyakov, A. A. Efremushkina, D. A. Zateyshchikov, V. V. Ivanenko, E. D. Kosmacheva, O. V. Krestyaninov, Yu. M. Lopatin, E. P. Panchenko, V. V. Ryabov, E. V. Samokhvalov, I. I. Staroverov, S. A. Ustyugov, A. V. Khripun, S. V. Shalaev, R. M. Shakhnovich, I. S. Yavelov, A. N. Yakovlev, S. S. Yakushin   +24 more
doaj   +1 more source

Stroke‐Heart Syndrome: Mechanisms, Temporal Phenotypes, and Diagnostic Reasoning

Advanced Science, EarlyView.
Stroke‐heart syndrome describes new or worsened cardiac abnormalities after acute stroke. This Review defines its clinical boundaries, traces autonomic, inflammatory, endothelial, and supply‐demand mechanisms across time, and proposes provisional phenotypes that integrate lesion location, premorbid cardiac substrate, serial biomarkers ...
Fa Lin, Jian Lyu, Yanci Liu, Zhiyuan Feng, Jie Bao, Wenxiong Song, Bingcheng Zhu, Minghao Liu, Jionghao Xue, Jiadi Weng, Jiani Zhang, Jizong Zhao, Xiaolin Chen, Bin Dong   +13 more
wiley   +1 more source

Serum Concentrations of Matrix Metalloproteinase‐1 and Procollagen Type I Carboxy Terminal Propeptide Discriminate Infarct‐Like Myocarditis and Non−ST‐Segment−Elevation Myocardial Infarction

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background Biomarkers simplifying the diagnostic workup by discriminating between non–ST‐segment–elevation myocardial infarction (NSTEMI) and infarct‐like myocarditis are an unmet clinical need.
Lucas Bacmeister, Ersin Cavus, Sebastian Bohnen, Enver Tahir, Hanna Wolf, Annette Buellesbach, Adrian Heidenreich, Virginia K. Haacke, Susanne Weber, Ingo Hilgendorf, Tanja Zeller, Francisco Ojeda, Ulf K. Radunski, Gunnar K. Lund, Gerhard Adam, Stefan Blankenberg, Dirk Westermann, Kai Muellerleile, Diana Lindner   +18 more
doaj   +1 more source

Acute coronary syndrome: analysis of two case reports

Clinical Management Issues, 2009
The patients presenting acute coronary syndrome without ST segment elevation can have a short and long-term risk of death or recurrent ischemic events. Therefore, the evaluation of risk is an essential step in the management of such patients.
Marco Mascellanti
doaj   +1 more source